Groundbreaking cancer trial

LINCOLNSHIRE women are being called on to participate in a worldwide breast cancer study which is being funded by Cancer Research UK.

Everyday, around ten women are diagnosed with breast cancer in the East Midlands

So, as October is breast cancer awareness month, Cancer Research UK is highlighting A groundbreaking breast cancer prevention trial called IBIS-2.

IBIS-2 is investigating whether the drug anastrozole could help women who are at high risk of developing the disease.

The study is being conducted at Grantham and District Hospital, Lincoln County Hospital and the Pilgrim Hospital, Boston.

It is open to post-menopausal women (who have stopped having regular periods), who are aged between 40-70 years, are not on HRT, and have a family history of breast cancer or other risk factors (such as certain types of non-cancerous breast lumps).

Women wishing to find out if they are eligible to take part should visit or call 0800 111 4134.